" ... and 16% among high-risk pts. It also detected precancerous high-grade dysplasia in more than 64% of cases." 2/2 #CanSky #PanCan

@albomp.bsky.social Prime Minister, sir with the utmost respect, could you please support urgent TGA assessment of daraxonrasib (RASONQUE), recently FDA-approved for metastatic pancreatic cancer, and subsequent PBS listing? For Australian patients like myself, access would be life-changing. #pancan
New KRAS treatment options are changing what's possible for pancreatic cancer patients. Thanks to the Pancreatic Cancer Action Network, #SmartPatients were able to ask GI oncologist Dr. Noelle LoConte questions about these findings. Read more: https://ow.ly/r0Ym50ZKItk